As the new year kicks off, the company forges ahead with pragmatic efforts! While many are still immersed in the festive atmosphere of the Spring Festival, Anhui Jingke Biotechnology Co., Ltd. has accelerated full resumption of work and production amid booming production and robust order fulfillment. All production lines are running at full capacity to fuel high-quality development in the new year. Against such a promising backdrop, Mr. Fu Yutang, Chairman of Liyuan Group, led the core management team for a special visit to Jingke Biotechnology on March 5th and 6th. Mr. Xu Hai, Chairman of Anhui Jingke Biotechnology Co., Ltd., and Mr. Gao Jianwei, General Manager, extended a warm welcome to the distinguished guests from Liyuan Group and accompanied the entire site tour and in-depth forum. This first visit of the year marks a vital milestone for the two powerhouse enterprises to deepen mutual trust and pursue coordinated growth, sending a strong signal for accelerated collaboration in the booming synthetic biology industry.
Visit to Jingke’s Hefei R&D Center: Proven Strength Backs Innovative R&D for Full-Biomanufacturing Industrial Chain Development
Core strengths showcased to earn high recognition: At Jingke’s Hefei R&D Center, Chairman Xu Hai, General Manager Gao Jianwei together with Zhang Zhongtao, General Manager of Hefei Jingke, gave a detailed briefing to Chairman Fu Yutang and his entourage covering the company’s core technological advantages, latest R&D breakthroughs and long-term strategic layout. The visiting team was deeply impressed by the team’s innovative vitality and rigorous work ethos. Chairman Fu Yutang spoke highly of Jingke’s outstanding performance and affirmed its profound technical accumulation and mature industrialization capacity in biosynthesis. He showed keen interest and full recognition across multiple dimensions including solid research capabilities, cutting-edge technologies and competitive product pipelines under development.
Both parties reached a consensus that Liyuan’s strengths in large-scale production and capital operation complement Jingke’s pioneering synthetic biology technologies as well as professional R&D and production management expertise. Such synergistic integration can drastically shorten the lead time for R&D commercialization and market expansion, deliver win-win outcomes in both commercial returns and social benefits, and better satisfy robust market demand for Jingke’s premium products.
Beyond one-off cooperation toward long-term integrated development: During candid discussions between Chairman Xu Hai, General Manager Gao Jianwei and the Liyuan delegation, in-depth strategic cooperation stood out as a core agenda item. Both sides will prudently evaluate diverse cooperation models to build a closer community of shared interests, maximize synergistic gains, seize market opportunities and jointly tackle industrial challenges.
Tongling Production Base: Robust Manufacturing Capacity Demonstrates Mature Closed-Loop Industrial Ecosystem
On March 6th, accompanied by Chairman Xu Hai, General Manager Gao Jianwei and Wang Shudong, General Manager of Tongling Jingke, Chairman Fu Yutang and his team toured Tongling Jingke’s manufacturing plant and witnessed the site’s bustling production activities and streamlined operational management on-site.
March Forward Hand in Hand: Ride Industry Momentum to Scale New Industrial Heights
Liyuan Group’s core team kicked off its first new-year visit amid Jingke’s vigorous post-holiday resumption of production and robust order backlog. The visit represents a strategic partnership linking abundant capital resources with advanced core technologies, strong market demand and ambitious industrial aspirations, embodying in-depth consensus and forward-looking blueprint between the two enterprises. Inspiring idea exchanges in Hefei and on-site inspection of thriving production in Tongling have laid a solid foundation of mutual trust for future all-round cooperation.
“Spring tides surge ahead while cooperation sparks splendid prospects. From insightful idea alignment at the R&D center to tangible strength displayed at the production base, Jingke Biotechnology and Liyuan Group are advancing steadily along the path of cooperation. Rooted in respective industrial strengths and united by concerted efforts, we are poised to deepen cultivation in the industrialization of synthetic biology and embrace a prosperous shared future.”
